Jutro Medical Secures €12 Million
Jutro Medical Secures €12 Million to Expand AI-Powered Primary Care Across Europe
Polish healthtech startup Jutro Medical has raised €12 million in Series A funding to accelerate the expansion of its AI-driven primary care model across Europe. The investment round was led by KAYA VC and RIO ASI, with continued participation from existing investor Inovo VC. A debt component was also provided by mBank.
Founded in 2020 by Adam Janczewski, Jutro Medical combines artificial intelligence with traditional healthcare services to streamline primary care delivery. The company operates as a hybrid provider, integrating telemedicine with physical clinics while leveraging AI agents that automate repetitive tasks commonly performed by doctors and medical staff.
Subscribe to Startup Digest to stay ahead with the latest news, investments, and must-attend events.
Jutro Medical’s proprietary AI agents are designed to handle up to 68 percent of teleconsultation tasks, including patient intake and post-visit documentation. This enables doctors to focus entirely on diagnosis and treatment. For straightforward cases, the AI reduces the average appointment time to 2 minutes and 37 seconds. However, final medical decisions remain the sole responsibility of licensed physicians.
The AI system is fully integrated into Jutro Medical’s proprietary electronic health record (EHR) platform, ensuring complete control over data privacy and compliance. Patients have the option to use AI-assisted consultations or continue with traditional online or in-person visits.
According to Adam Janczewski, CEO and Founder of Jutro Medical, “When you break down complex healthcare delivery into hundreds of tasks done daily by doctors and medical staff, you discover that only a small fraction truly relates to medicine and health. Our goal is to develop medical AI agents capable of taking over these administrative tasks, allowing doctors to practice medicine as it should be.”
The new funding will support Jutro Medical’s continued growth in Poland and its entry into new European markets. The company is preparing to open its first clinic in the Netherlands while expanding its presence in existing locations.
Investor KAYA VC, based in Czechia, focuses on early-stage investments in Central and Eastern Europe, particularly in software, healthcare, and SaaS sectors. RIO ASI, a Warsaw-based single-family office, manages a diversified portfolio with a strong focus on high-impact investments in consumer, technology, manufacturing, and real estate sectors.
Jutro Medical’s model represents a significant shift in healthcare delivery, offering scalable solutions to improve efficiency while preserving the integrity of the doctor-patient relationship. The integration of AI into everyday clinical practice reflects a growing trend toward technology-driven healthcare that prioritizes both quality of care and operational efficiency.
With this latest round of funding, Jutro Medical is positioned to play a leading role in shaping the future of primary care in Europe.
